• Service: Tax
  • Industry: Infrastructure, Government and Healthcare, Healthcare, Global China Practice
  • Type: Business and industry issue, Survey report
  • Date: 10/31/2013

Site Selection for Life Sciences Companies: Cluster Report 2013 

Access to new technologies, products, talent and markets is critical for Life Sciences (LS) companies' efforts to maintain competiveness and generate growth in an environment characterized by price pressures, fast technological changes and increasingly sophisticated consumers.

Europe is especially interesting for Life Sciences companies from emerging economies and the US seeking to leverage these potential advantages. With its technological leadership and manufacturing know-how, Europe offers interesting opportunities for the acquisition or development of intellectual property (IP ) as well as the production of sophisticated products.



Related links





Get in touch with KPMG China



Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.